SINGAPORE – The deadly consequences of hoarding were highlighted after a fire in a Hougang flat killed three people on Jan 9. Neighbours had said the family living in the unit were hoarders.
Storm Éowyn will be a “dangerous, destructive” weather event and among the most severe storms Ireland has ever experienced, the chair of the National Emergency Co-ordination Group (NECG) ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant depression. This marks a significant advancement in depression treatment ...
Targets nasal congestion and sinus pressure at the source by reducing swelling in the sinuses Breathe better all day or all night long with Vicks Sinex Severe. For instant, 12-hour, nasal ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Hosted on MSN18d
FDA approves first nasal spray treatment for severe depressionThe FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe depression. It is now the first-ever stand-alone therapy for treatment ...
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results